Your global observational studies
service provider

We offer a combination of high quality science and operational experience to provide pharma companies worldwide with real-world evidence for safety, market access and drug development.

SEND US YOUR RFI/RFP

Academic Research Collaboration

OXON's COVID-19
Research Programme

"OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors"

ONGOING PROJECTS

Real-World Evidence & Trials
Free Live Masterclass Series 2021

Attend to learn about the role and pros and cons of Real-World Data studies compared with trials. Guidance to overcome challenges in future RWE studies will be discussed with Q&A sessions for non-technical and technical questions.

EXPLORE

SERVICES

As your Contract Research Organization, at OXON we plan and implement the generation of Real-World patient centred evidence

KNOW MORE

STUDIES

We help you to effectively meet the requirements of late-phase clinical studies for better outcomes or greater value

KNOW MORE

THERAPEUTIC AREAS

OXON offers proven trial experience and a portfolio of completed studies and publications in a broad range of therapeutic areas

KNOW MORE

A few things we’re great at

OXON has been selected as a preferred provider by several big pharma companies.

READ ABOUT US

WORLD CLASS SCIENCE

Our specialization and high calibre allows us to have clear focus, deep expertise and superior insight to provide concrete results with maximum value to our clients.

GLOBAL REACH

We are specialised in multi-country observational studies and provide our real-world evidence services worldwide with the expertise and multi-language capabilities of our local partners.

STRONG LINKS

OXON’s services are reinforced with academic links with the London School of Hygiene & Tropical Medicine and with leading academic methodological and clinical consultants.

LONG TERM ALLIANCES

OXON has a long-term alliance with a top tier global CRO that provides us in-depth understanding of local requirements while keeping the flexibility needed to compete with the largest CROs.

We strive our best to support our clients in conducting cost-efficient observational studies worldwide

We pulled together
professionals and resources to serve you better

Let us help design and conduct your optimal PASS or Outcomes observational study

OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, 30+ NEJMs and 40+ Lancets)

REQUEST A MEETING

Newsroom

Read about us, our latest news and events

Your global observational studies
service provider

OXON's COVID-19
Research Programme